Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk

Journal of the American Society of Nephrology

Volumn 18, Issue 7, 2007, Pages 2161-2171

  Feldt Rasmussen, Bo ^a,i   Lange, Martin ^b   Sulowicz, Wladyslaw ^c   Gafter, Uzi ^d   Kar, Neng Lai ^e   Wiedemann, Jonas ^g   Christiansen, Jens Sandal ^f   El Nahas, Meguid ^h   Sulkova, S ^j   Feldt Rasmussen, B ^a   Madsen, M ^f   Hannedouche, T ^k   Lai, K N ^l   Holtzman, E ^m   Gafter, U ^d   Schwartz, D ⁿ   Katzir, Z ^o   Weissgarten, J ^p   Majdan, M ^q   Niemczyk, S ^r   Sulowicz, W ^c   Lee, K O ^s   Ahlmen, J ^t   El Nahas, M ^h   Mitra, S ^u   Rodger, R S C ^v   Tapson, J S ^w   Rustom, R ^x   Ayub, W ^y   Mikhail, A ^z   Thomas, M ^aa   more..

^a Mental Health Services CPH   (Denmark)

^b NOVO NORDISK INC   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d RABIN MEDICAL CENTER   (Israel)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g NOVO NORDISK A S   (Denmark)

^h NORTHERN GENERAL HOSPITAL   (United Kingdom)

ⁱ Rigshospitalet   (Denmark)

^j CHARLES UNIVERSITY   (Czech Republic)

^k UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^l QUEEN MARY HOSPITAL   (Hong Kong)

^m SHEBA MEDICAL CENTER   (Israel)

ⁿ TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^o WOLFSON MEDICAL CENTER   (Israel)

^p ASSAF HAROFEH MEDICAL CENTER   (Israel)

^q Klinika Chorob Nerek   (Poland)

^r Oddzial Chorob Wewnetrznych   (Poland)

^s NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^t Lundby Sjukhus   (Sweden)

^u MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^v WESTERN INFIRMARY   (United Kingdom)

^w FREEMAN HOSPITAL   (United Kingdom)

^x Duncan Building   (United Kingdom)

^y WALSGRAVE HOSPITAL   (United Kingdom)

^z MORRISTON HOSPITAL   (United Kingdom)

^aa BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HUMAN GROWTH HORMONE; PLACEBO; SERUM ALBUMIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ADULT; AGED; ANOREXIA; ARTHRALGIA; ARTHRITIS; ARTICLE; BRONCHITIS; BRONCHOPNEUMONIA; CARDIOMEGALY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DIARRHEA; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FLUID RETENTION; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; KIDNEY FAILURE; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; LUNG CONGESTION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NAUSEA; NEUROENDOCRINE TUMOR; NUTRITION; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PAIN; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHORT FORM 36; SIDE EFFECT; SPINAL CORD ISCHEMIA; THORAX PAIN; TRANSFERRIN BLOOD LEVEL;

EID: 34447293565     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006111207     Document Type: Article

References (54)

1. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
2. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 50: 343-357, 1996
3. Mehrotra R, Kopple JD: Nutritional management of maintenance dialysis patients: Why aren't we doing better? Annu Rev Nutr 21: 343-379, 2001
4. Sharma RK, Sahu KM: Nutrition in dialysis patients. J Indian Med Assoc 99: 206-208, 210-211, 213, 2001
5. Rocco MV, Paranandi L, Burrowes JD, Cockram DB, Dwyer JT, Kusek JW, Leung J, Makoff R, Maroni B, Poole D: Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis 39: 245-256, 2002
6. Navarro JF, Mora C: In-depth review effect of androgens on anemia and malnutrition in renal failure: Implications for patients on peritoneal dialysis. Perit Dial Int 21: 14-24, 2001
7. Cano N, Labastie-Coeyrehourq J, Lacombe P, Stroumza P, di Costanzo-Dufetel J, Durbec JP, Coudray-Lucas C, Cynober L: Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 52: 726-730, 1990
8. Sharma M, Rao M, Jacob S, Jacob CK: A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients. J Ren Nutr 12: 229-237, 2002
9. Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A: Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant 16: 1856-1862, 2001
10. Eustace JA, Coresh J, Kutchey C, Te PL, Gimenez LF, Scheel PJ, Walser M: Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. Kidney Int 57: 2527-2538, 2000
11. Tietze IN, Pedersen EB: Effect of fish protein supplementation on aminoacid profile and nutritional status in haemodialysis patients. Nephrol Dial Transplant 6: 948-954, 1991
12. Acchiardo S, Moore L, Cockrell S: Effect of essential amino acids (EAA) on chronic hemodialysis (CHD) patients (PTS). Trans Am Soc Artif Intern Organs 28: 608-614, 1982
13. Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR: Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr 11: 9-15, 2001
14. Fryburg DA, Gelfand RA, Barrett EJ: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 260: E499-E504, 1991
15. Fryburg DA, Barrett EJ: Physiological effects and potential applications of GH and IGF-I. Diabetes Nutr Metab 12: 329-336, 1999
16. Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N: The protein-retaining effect of growth hormone during fasting involves inhibition of muscle-breakdown. Diabetes 50: 96-104, 2001
17. Golde DW, Bersch N, Li CH: Growth hormone: Species-specific stimulation of erythropoiesis in vitro. Science 196: 1112-1113, 1977
18. Kotzmann H, Riedl M, Clodi M, Barnas U, Kaider A, Hocker P, Luger A: The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur J Clin Invest 26: 1175-1181, 1996
19. Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, Frenneaux MP, Rees A, Scanlon MF: The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 142: 254-262, 2000
20. Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G: Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients, with GH deficiency. J Clin Endocrinol Metab 86: 1874-1881, 2001
21. Elhadd TA, Abdu TA, Oxtoby J, Kennedy G, McLaren M, Neary R, Belch JJ, Clayton RN: Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J Clin Endocrinol Metab 86: 4223-4232, 2001
22. Tonshoff B, Schaefer F, Mehls O: Disturbance of growth hormone-insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment. Pediatr Nephrol 4: 654-662, 1990
23. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5: 539-544, 1991
24. Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW: Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 2: 1130-1135, 1991
25. Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM: Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 46: 1178-1183, 1994
26. Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorini F, Minuto F, Tizianello A: Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 99: 97-105, 1997
27. Iglesias P, Diez J, Fernandez-Reyes MJ, Aguilera A, Burgues S, Martinez-Ara J, Miguel JL, Gomez-Pan A, Selgas R: Recombinant human growth hormone therapy in malnourished dialysis patients: A randomized controlled study. Am J Kidney Dis 32: 454-463, 1998
28. Sohmiya M, Ishikawa K, Kato Y: Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failure. Eur J Endocrinol 138: 302-306, 1998
29. Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS: Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Clin Nephrol 52: 103-109, 1999
30. Johannsson G, Bengtsson BA, Ahlmen J: Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement. Am J Kidney Dis 33: 709-717, 1999
31. Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB: Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol 53: 99-9107, 2000
32. Kotzmann H, Yilmaz N, Lercher P, Riedl M, Schmidt A, Schuster E, Kreuzer S, Geyer G, Frisch H, Horl WH, Mayer G, Luger A: Differential effects of growth hormone therapy in malnourished hemodialysis patients. Kidney Int 60: 1578-1585, 2001
33. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251-1263, 2001
34. Kalantar-Zadeh K, Kopple JD: Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38: 1343-1350, 2001
35. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD: A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15: 442-453, 2004
36. Kirsch R, Frith L, Black E, Hoffenberg R: Regulation of albumin synthesis and catabolism by alteration of dietary protein. Nature 217: 578-579, 1968
37. Clinical research guidelines for nutrition in chronic renal failure. K/DOQI National Kidney Foundation. Am J Kidney Dis 35[suppl 2]: S1-S140, 2000
38. Rotschild MA, Oratz M, Schreiber SS: Albumin synthesis. 1. N Engl J Med 286: 748-757, 1972
39. Greenblatt DJ: Reduced serum albumin concentration in the elderly: A report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 27: 20-22, 1979
40. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH: Study on the molecular mechanism of the decreased liver synthesis of albumin in inflammation. J Hepatol 5: S173, 1987
41. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
42. Rao M, Guo DQ, Perianayagam MC, Tighiouart H, Jaber BL, Pereira BJG, Balakrishnan VS: Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 45: 324-333, 2005
43. Rigaud D, Hassid J, Meulemans A, Poupard AT, Boulier A: A paradoxical increase in resting energy expenditure in malnourished patients near death: The king penguin syndrome. Am J Clin Nutr 72: 355-360, 2000
44. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990
45. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
46. Rocco MV, Frankenfield DL, Hopson SD, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 145: 512-519, 2006
47. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S: Revisiting mortality predictability of serum albumin in the dialysis population: Time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20: 1880-1888, 2005
48. Kotzmann H, Schmidt A, Lercher P, Schuster E, Geyer G, Frisch H, Horl WH, Mayer G, Luger A: One-year growth hormone therapy improves granulocyte function without major effects on nutritional and anthropometric parameters in malnourished hemodialysis patients. Nephron Clin Pract 93: C75-C82, 2003
49. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK: Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64: 339-349, 2003
50. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD: Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83: 202-210, 2006
51. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14: 2366-2372, 2003
52. ICH Harmonised Tripartite Guideline. E6 (R1) Guideline for Good Cinical Practice. June 10, 1996. Geneva, Switzerland. Available online at www.ich.org/LOB/media/MEDIA482.pdf. Accessed May 24, 2007
53. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 284: 3043-3045, 2000
54. Flint A, Raben A, Blundell JE, Astrup A: Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24: 38-48, 2000